Here is good news for patients with multiple sclerosis or MS. Actually, a new study, by the U.S. researchers has come up with such a conclusion that has given researchers a reason to believe that soy-based substance called Bowmann-Birk Inhibitor Concentrate or BBIC can help patients with multiple sclerosis, a nervous system inflammation.
Before uncovering this fact, researchers studied the impact of BBIC on a group of animals with multiple sclerosis like disease and found that BBIC had good effect on animals with MS like disease on the other hand; animals with same disease who didn’t receive BBIC but an inert substance didn’t show such improvement.
These results are really very convincing, which have given researchers a hope to believe that this finding may prove a major breakthrough for treating patients with multiple sclerosis. However, it may take some time; therefore, all of us will have to wait for the day when this study come up with final results.
Image credit: Science Museum
Via: Health Day